In this video, Dr Regueiro, chief of gastroenterology, hepatology, and nutrition at the Cleveland Clinic and Inflammatory Bowel Disease Section Editor for Gastroenterology Learning Network, discusses his presentation on managing the patient hospitalized with severe ulcerative colitis. He will present on this topic at the upcoming Advances in Inflammatory Bowel Diseases virtual regional meeting on March 6.
Dr Hudesman, from NYU Langone Health, discusses the case of a pregnant patient who presented with severe acute ulcerative colitis and also tested positive for COVID-19.
Dr Regueiro and Dr Huang, from the Cleveland Clinic, discuss the development of a novel disease model to identify targets for future ulcerative colitis therapeutic agents.
Joseph Feuerstein, MD, on the AGA Clinical Guidelines for Managing Moderate to Severe Ulcerative Colitis
Dr Feuerstein chaired the guideline panel that developed the American Gastroenterological Association's new guidelines on managing ulcerative colitis. He sat down with Gastroenterology Learning Network to answer a few questions.
In this video, Michael Chiorean, MD, reviews how JAK inhibitors, IL-12/23 inhibitors, and other, newer therapies are expanding the tools for management of ulcerative colitis.
Dr Chiorean, from Virginia Mason Medical Center in Seattle, continues his discussion on available therapies for ulcerative colitis and Crohn disease, and how to stage them for the optimum patient outcomes.
In this video, Marla Dubinsky, MD, codirector of the Susan and Leonard Feinstein IBD Center at the Icahn School of Medicine at Mount Sinai in New York, discusses how to use the professional society guidelines as a framework for choosing therapeutics for patients with ulcerative colitis.
Dr Barnes discusses the factors to consider when determining when and how to position therapeutic options, including surgery, for patients with ulcerative colitis.
In this 4-minute video, Raymond Cross, MD, from the University of Maryland, reviews his discussion of managing patients with mild to moderate ulcerative colitis, which he presented at the virtual Advances in Inflammatory Bowel Disease regional meeting on September 12.
He recaps his presentation at the August 22 AIBD regional meeting on treating patients with ulcerative colitis with new and emerging therapeutic agents.